Patents by Inventor Rajee Antony

Rajee Antony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-RAF Mutants that Confer Resistance to RAF Inhibitors
    Publication number: 20240093310
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Application
    Filed: September 11, 2023
    Publication date: March 21, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF mutants that confer resistance to RAF inhibitors
    Patent number: 11788151
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: October 17, 2023
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF Mutants that Confer Resistance to RAF Inhibitors
    Publication number: 20210388325
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Application
    Filed: August 11, 2021
    Publication date: December 16, 2021
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF Mutants that Confer Resistance to RAF Inhibitors
    Publication number: 20190142830
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 16, 2019
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF Mutants that Confer Resistance to RAF Inhibitors
    Publication number: 20170204383
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Application
    Filed: March 29, 2017
    Publication date: July 20, 2017
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF mutants that confer resistance to RAF inhibitors
    Patent number: 9629839
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: April 25, 2017
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
  • C-RAF MUTANTS THAT CONFER RESISTANCE TO RAF INHIBITORS
    Publication number: 20150133478
    Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.
    Type: Application
    Filed: March 7, 2013
    Publication date: May 14, 2015
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway